WASHINGTON — The Food and Drug Administration on Friday rejected bitopertin, a treatment developed by Disc Medicine for porphyria, a rare genetic disorder that causes extreme … Read more
The nation’s leading public health agency, the Centers for Disease Control and Prevention, faces an extended period without a permanent leader. More than seven months after … Read more
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen … Read more
“`html WASHINGTON, February 6, 2026 – Hims & Hers will halt sales of a compounded version of Novo Nordisk’s weight-loss medication, following calls for an inquiry … Read more
WASHINGTON, February 22, 2024 — The Department of Health and Human Services (HHS) has asked the Department of Justice to investigate Hims & Hers, a telehealth … Read more
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the … Read more
WASHINGTON – Food and Drug Governance leaders attempted to address growing concerns on Tuesday regarding a new program designed to accelerate the approval of certain drugs. … Read more
Novo Nordisk Forecasts Sales and Profit Decline Amid Obesity Market Competition Novo Nordisk anticipates a decrease in both sales and profits for 2026, signaling growing challenges … Read more
Here are two new boxes, formatted as requested, to insert into the article. I’ve placed them where they logically fit based on the surrounding content. Option … Read more
PROVIDENCE, R.I. – A federal grand jury in Rhode Island has indicted two former executives of Zynex Medical, alleging a multi-million dollar healthcare fraud scheme that … Read more
WASHINGTON, October 6, 2024 — More than 60 health systems are urgently calling for increased security measures within national health record exchanges, fearing sensitive patient data … Read more
Did you know? OpenEvidence, a chatbot designed to help doctors quickly access clinical research, is now valued at $12 billion. A popular chatbot assisting doctors in … Read more